Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00912444
Brief Title: Neoadjuvant Treatment of Docetaxel, Anthracycline and Cyclophosphamide (TAC) Versus Docetaxel and Cyclophosphamide (TC) in Triple-Negative or Her2 Positive Breast Cancer (NATT)

First Submitted : June 1, 2009
First Submitted that Met QC Criteria : June 2, 2009
First Posted : June 3, 2009 (Estimate)

Last Update Submitted that Met QC Criteria : November 19, 2016
Last Update Posted : November 22, 2016 (Estimate)